{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:03:23Z","timestamp":1794330203802,"version":"4.9.0"},"reference-count":28,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare of Japan","doi-asserted-by":"crossref","award":["20FC1030"],"award-info":[{"award-number":["20FC1030"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2022,8,20]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>There was no nationwide epidemiological study of Lambert-Eaton myasthenic syndrome (LEMS) in Japan; therefore, we conducted a nationwide survey.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>For the first survey, we sent survey sheets to randomly selected medical departments (n=7545) to obtain the number of LEMS who visited medical departments between 1 January 2017 and 31 December 2017. For the second survey, we sent survey sheets to the corresponding medical departments to obtain clinical information on LEMS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We received 2708 responses (recovery rate: 35.9%) to the first survey. We estimated the number of LEMS as 348 (95% CI 247 to 449). The prevalence was 2.7 (95% CI 1.9 to 3.5) in 1\u2009000\u2009000 population. As a result of the second survey, we obtained 30 case records of 16 men and 14 women. Fourteen patients (46.7%) had a tumour, and 10 out of 14 tumours were small-cell lung carcinoma (71.4%). There was a predominance of men in the LEMS with tumour (paraneoplastic LEMS, P-LEMS) (n=11, 78.6%) and women in the LEMS without tumour (a primary autoimmune form of LEMS, AI-LEMS) (n=11, 68.8%) (p=0.0136). The onset age (mean (SD)) for the P-LEMS was 67.1 (9.0), and that for AI-LEMS was 57.8 (11.2) years old (p=0.0103). The disease duration (median) for P-LEMS was 2 years, and for AI-LEMS was 7.5 years (p=0.0134).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The prevalence of LEMS in Japan is similar to that in other countries. There are predominances of men in P-LEMS and women in AI-LEMS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2022-000291","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T12:06:35Z","timestamp":1662379595000},"page":"e000291","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6350-5183","authenticated-orcid":false,"given":"Hiroaki","family":"Yoshikawa","sequence":"first","affiliation":[{"name":"Health Service Center, Kanazawa University, Kanazawa, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Adachi","sequence":"additional","affiliation":[{"name":"Health Service Center, Kanazawa University, Kanazawa, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosikazu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Public Health, Jichi Medical University, Shimotsuke, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagato","family":"Kuriyama","sequence":"additional","affiliation":[{"name":"Department of Social Health Medicine, Shizuoka Graduate University of Public Health, Shizuoka, Japan"},{"name":"Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Murai","sequence":"additional","affiliation":[{"name":"Neurology, International University of Health and Welfare, Otawara, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Nomura","sequence":"additional","affiliation":[{"name":"Pediatric Neurology, Yoshiko Nomura Neurological Clinic for Children, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Iwasa","sequence":"additional","affiliation":[{"name":"Health Science, Ishikawa Prefectural Nursing University, Kahoku-gun, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurobiology of Aging, Kanazawa University, Kanazawa, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-8578","authenticated-orcid":false,"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[{"name":"Neurology, Chiba University Graduate School of Medicine School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Matsui","sequence":"additional","affiliation":[{"name":"Neurology, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"2025072811233269000_4.2.e000291.1","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11081035","article-title":"Presynaptic paraneoplastic disorders of the neuromuscular junction: an update","volume":"11","author":"Giannoccaro","year":"2021","journal-title":"Brain Sci"},{"key":"2025072811233269000_4.2.e000291.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2014.11.022"},{"key":"2025072811233269000_4.2.e000291.3","article-title":"Recent advances and therapeutic options in Lambert-Eaton myasthenic syndrome","volume":"11","author":"Anwar","year":"2019","journal-title":"Cureus"},{"key":"2025072811233269000_4.2.e000291.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70245-9"},{"key":"2025072811233269000_4.2.e000291.5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2008.05.025","article-title":"The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients","volume":"201-202","author":"Titulaer","year":"2008","journal-title":"J Neuroimmunol"},{"key":"2025072811233269000_4.2.e000291.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1957.02970480021005"},{"key":"2025072811233269000_4.2.e000291.7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0025-7125(16)33984-0","article-title":"Myasthenia and malignant intrathoracic tumor","volume":"44","author":"Rooke","year":"1960","journal-title":"Med Clin North Am"},{"key":"2025072811233269000_4.2.e000291.8","doi-asserted-by":"crossref","unstructured":"Dresser L , Wlodarski R , Rezania K . Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. J Clin Med 2021;10(11).","DOI":"10.3390\/jcm10112235"},{"key":"2025072811233269000_4.2.e000291.9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.26885","article-title":"Lowering the cutoff value for increment increases the sensitivity for the diagnosis of Lambert-Eaton myasthenic syndrome","volume":"62","author":"Lipka","year":"2020","journal-title":"Muscle Nerve"},{"key":"2025072811233269000_4.2.e000291.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506013322203"},{"key":"2025072811233269000_4.2.e000291.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.24.7636"},{"key":"2025072811233269000_4.2.e000291.12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/nyas.13512","article-title":"Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads","volume":"1412","author":"Meriney","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"2025072811233269000_4.2.e000291.13","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00415-017-8541-9","article-title":"Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer","volume":"264","author":"Schoser","year":"2017","journal-title":"J Neurol"},{"key":"2025072811233269000_4.2.e000291.14","unstructured":"Nakamura Y . National epidemiological survey manual for grasping number of patients with intractable disease and clinical epidemiological image. 3rd edition, 2017."},{"key":"2025072811233269000_4.2.e000291.15","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000037485.56217.5F"},{"key":"2025072811233269000_4.2.e000291.16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/01.WNL.0000130254.27019.14","article-title":"The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands","volume":"63","author":"Wirtz","year":"2004","journal-title":"Neurology"},{"key":"2025072811233269000_4.2.e000291.17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/mus.25520","article-title":"Lambert-Eaton myasthenic syndrome: epidemiology and therapeutic response in the National Veterans Affairs population","volume":"56","author":"Abenroth","year":"2017","journal-title":"Muscle Nerve"},{"key":"2025072811233269000_4.2.e000291.18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","article-title":"Small-Cell lung cancer","volume":"378","author":"van Meerbeeck","year":"2011","journal-title":"The Lancet"},{"key":"2025072811233269000_4.2.e000291.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0440"},{"key":"2025072811233269000_4.2.e000291.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(02)00054-9"},{"key":"2025072811233269000_4.2.e000291.21","first-page":"S21","article-title":"Autoimmunity in the Lambert-Eaton myasthenic syndrome","volume":"5","author":"Lennon","year":"1982","journal-title":"Muscle Nerve"},{"key":"2025072811233269000_4.2.e000291.22","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/111.3.577"},{"key":"2025072811233269000_4.2.e000291.23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2188\/jea.JE20200025","article-title":"Widening socioeconomic inequalities in smoking in Japan, 2001-2016","volume":"31","author":"Tanaka","year":"2021","journal-title":"J Epidemiol"},{"key":"2025072811233269000_4.2.e000291.24","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20672"},{"key":"2025072811233269000_4.2.e000291.25","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S10464"},{"key":"2025072811233269000_4.2.e000291.26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1212\/WNL.0000000000003794","article-title":"Long-Term survival in paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"88","author":"Maddison","year":"2017","journal-title":"Neurology"},{"key":"2025072811233269000_4.2.e000291.27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.10.1552"},{"key":"2025072811233269000_4.2.e000291.28","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.38.9.1391","article-title":"Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer","volume":"38","author":"Anderson","year":"1988","journal-title":"Neurology"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2022-000291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:23:39Z","timestamp":1753727019000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2022-000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,9,5]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/bmjno-2022-000291"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2022-000291","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}